Abstract
A total of 318 consecutive myeloma patients underwent whole-body low-dose CT scan (WBLDCT) at baseline and during follow-up as a radiological assessment of lytic lesions in place of skeletal X-ray survey. After WBLDCT baseline assessment, 60% had bone involvement. The presence of lytic lesions represented the only met CRAB (hyperCalcaemia, Renal insufficiency, Anaemia, Bone lesions) criteria in 29% of patients. Patients presenting with extramedullary masses were 10%. Radiological progression was documented in 9% of the population with available follow-up. Additional pathological incidental findings were detected in 28 patients (14.5%), most located in the chest region (68%). In conclusion, our real-life data shows that WBLDCT scan represents a reliable imaging tool for decision-making process for multiple myeloma management in different disease phases, providing significant additional information on the presence of soft tissues plasmacytomas detection as well as the presence of pathological incidental findings.
References
Jun 5, 2003·British Journal of Haematology·UNKNOWN International Myeloma Working Group
Apr 20, 2005·European Journal of Radiology·Marius HorgerChristina Pfannenberg
Jun 2, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Terpos, M-A Dimopoulos
Jun 17, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Brian G M Durie
Feb 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald WalkerEdgardo J Angtuaco
Oct 10, 2007·European Radiology·Patric KröpilMathias Cohnen
Oct 31, 2008·Leukemia·R A Kyle, S V Rajkumar
Nov 15, 2008·Skeletal Radiology·T G GleesonS J Eustace
May 8, 2009·Leukemia·M DimopoulosUNKNOWN IMWG
May 16, 2009·Blood·Twyla B BartelBart Barlogie
Apr 30, 2010·Leukemia·L A MoulopoulosE Terpos
Dec 7, 2011·Academic Radiology·Daniel SpiraMarius Horger
Jan 8, 2013·Leukemia & Lymphoma·Jens Hillengass, Ola Landgren
Feb 15, 2013·Cancer Investigation·Kelechi PrincewillMichael Mulligan
Apr 27, 2013·British Journal of Haematology·Josien C RegelinkSonja Zweegman
Oct 1, 2013·European Journal of Radiology·Davide IppolitoSandro Sironi
May 6, 2014·European Journal of Radiology·Maya B WolfMarc-André Weber
Jul 10, 2014·The British Journal of Radiology·A SurovD Schramm
Oct 9, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matthew J PiankoSuzanne Lentzsch
Dec 3, 2014·The Lancet Oncology·S Vincent RajkumarJesus F San Miguel
Oct 4, 2015·Haematologica·Evangelos TerposUNKNOWN European Myeloma Network
Oct 18, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Cristina NanniStefano Fanti
Citations
Mar 2, 2019·Hematological Oncology·Nadia WithofsJo Caers
Dec 10, 2017·Skeletal Radiology·M HorgerChristopher Kloth
Dec 7, 2019·Hematology·Elisabet E Manasanch
Sep 2, 2017·Current Osteoporosis Reports·Cristina PanaroniNoopur S Raje
Jan 19, 2021·Dose-response : a Publication of International Hormesis Society·Dario BaldiMarco Salvatore